Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol for prevention of Adriamycin-induced acute cardiotoxicity in breast cancer
IRCT2013093012924N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of carvedilol in breast cancer and heart failure (HF), sponsored by Mashhad University of Medical Sciences. Started Apr 2012; status: completed.
02
Drugs
carvedilol
03
Conditions
breast cancerheart failure (HF)
Beyond the preview
Go deeper on IRCT2013093012924N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013093012924N1.